Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrata

Open access

Published version of a preprint

Abstract

Candida glabrata is a prominent opportunistic fungal pathogen of humans. The increasing incidence of C. glabrata infections is attributed to both innate and acquired resistance to antifungals. Previous studies suggest the transcription factor Pdr1 and several target genes encoding ABC transporters are critical elements of pleiotropic defense against azoles and other antifungals. This study utilizes Hermes transposon insertion profiling to investigate Pdr1-independent and Pdr1-dependent mechanisms that alter susceptibility to the frontline antifungal fluconazole. Several new genes were found to alter fluconazole susceptibility independent of Pdr1 ( CYB5 , SSK1 , SSK2 , HOG1 , TRP1 ). A bZIP transcription repressor of mitochondrial function ( CIN5 ) positively regulated Pdr1 while hundreds of genes encoding mitochondrial proteins were confirmed as negative regulators of Pdr1. The antibiotic oligomycin activated Pdr1 and antagonized fluconazole efficacy likely by interfering with mitochondrial processes in C. glabrata . Unexpectedly, disruption of many 60S ribosomal proteins also activated Pdr1, thus mimicking the effects of the mRNA translation inhibitors. Cycloheximide failed to fully activate Pdr1 in a cycloheximide-resistant Rpl28-Q38E mutant. Similarly, fluconazole failed to fully activate Pdr1 in a strain expressing a low-affinity variant of Erg11. Fluconazole activated Pdr1 with very slow kinetics that correlated with the delayed onset of cellular stress. These findings are inconsistent with the idea that Pdr1 directly senses xenobiotics and support an alternative hypothesis where Pdr1 senses cellular stresses that arise only after engagement of xenobiotics with their targets. IMPORTANCE: Candida glabrata is an opportunistic pathogenic yeast that causes discomfort and death. Its incidence has been increasing because of natural defenses to our common antifungal medications. This study explores the entire genome for impacts on resistance to fluconazole. We find several new and unexpected genes can impact susceptibility to fluconazole. Several antibiotics can also alter the efficacy of fluconazole. Most importantly, we find that Pdr1—a key determinant of fluconazole resistance—is not regulated directly through binding of fluconazole and instead is regulated indirectly by sensing the cellular stresses caused by fluconazole blockage of sterol biosynthesis. This new understanding of drug resistance mechanisms could improve the outcomes of current antifungals and accelerate the development of novel therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/msphere.00254-23

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Genome-wide analyses of fluconazole susceptibility in C. glabrata. Diverse pools of Hermes transposon insertion mutants were generated in three isogenic derivatives of strain BG2 (BG14, pdr1∆, and cdr1∆) and diluted into fresh medium containing or lacking 128 µg/mL fluconazole. The insertion sites were profiled using QI-seq, tabulated gene-wise, normalized, and plotted. Specific sets of genes were colorized: PDR1-CDR (green), UPC2A-ERG (orange), mitochondria (yellow), and 60S ribosome (blue). Other genes are specifically labeled.
FIG 1 Genome-wide analyses of fluconazole susceptibility in C. glabrata. Diverse pools of Hermes transposon insertion mutants were generated in three isogenic derivatives of strain BG2 (BG14, pdr1∆, and cdr1∆) and diluted into fresh medium containing or lacking 128 µg/mL fluconazole. The insertion sites were profiled using QI-seq, tabulated gene-wise, normalized, and plotted. Specific sets of genes were colorized: PDR1-CDR (green), UPC2A-ERG (orange), mitochondria (yellow), and 60S ribosome (blue). Other genes are specifically labeled.CC BY · PubMed Central
FIG 2 Mitochondria inhibitors antagonize fluconazole efficacy in Pdr1-dependent fashion. Growth of the wild-type BG14 and pdr1∆, cdr1∆, atp1∆, and atp1∆ pdr1∆ derivative strains was measured at 600 nm after 20 h incubation in SCD medium containing varying concentrations of fluconazole plus varying concentrations of either oligomycin. Data are plotted as a heatmap from saturation (yellow) to no growth (black). The IC50 of fluconazole was calculated for each row and the antagonism index (ai) was calculated for each dose of mitochondria inhibitor. The maximum ai for each strain and mitochondria inhibitor is indicated.
FIG 2 Mitochondria inhibitors antagonize fluconazole efficacy in Pdr1-dependent fashion. Growth of the wild-type BG14 and pdr1∆, cdr1∆, atp1∆, and atp1∆ pdr1∆ derivative strains was measured at 600 nm after 20 h incubation in SCD medium containing varying concentrations of fluconazole plus varying concentrations of either oligomycin. Data are plotted as a heatmap from saturation (yellow) to no growth (black). The IC50 of fluconazole was calculated for each row and the antagonism index (ai) was calculated for each dose of mitochondria inhibitor. The maximum ai for each strain and mitochondria inhibitor is indicated.CC BY · PubMed Central
FIG 3 Mitochondrial dysfunction alters CDR1 expression and fluconazole susceptibility. (A) Growth of kgd2∆ idh2∆ double and single gene knockout mutants was measured at 600 nm (OD600) after 20 h incubation at 30°C in SCD medium containing different doses of fluconazole. (B) CDR1 gene expression relative to TEF1 gene expression was measured by RT-PCR after 6 h exposure of log-phase cells to the indicated concentrations of fluconazole in SCD medium at 30°C. The data from three biological replicates were averaged (±SD) and normalized to BG14 parent strain in the absence of fluconazole. Values for BG14, kgd2∆, and pdr1∆ were multiplied by three to improve visibility. (C) Three independent cultures of strains BG14 and cin5∆ were grown to log phase in synthetic complete medium containing 2% dextrose or 2% glycerol while periodically measuring optical density at 600 nm. Exponential growth rates (k = ln2/doubling time) were averaged and charted (±SD).
FIG 3 Mitochondrial dysfunction alters CDR1 expression and fluconazole susceptibility. (A) Growth of kgd2∆ idh2∆ double and single gene knockout mutants was measured at 600 nm (OD600) after 20 h incubation at 30°C in SCD medium containing different doses of fluconazole. (B) CDR1 gene expression relative to TEF1 gene expression was measured by RT-PCR after 6 h exposure of log-phase cells to the indicated concentrations of fluconazole in SCD medium at 30°C. The data from three biological replicates were averaged (±SD) and normalized to BG14 parent strain in the absence of fluconazole. Values for BG14, kgd2∆, and pdr1∆ were multiplied by three to improve visibility. (C) Three independent cultures of strains BG14 and cin5∆ were grown to log phase in synthetic complete medium containing 2% dextrose or 2% glycerol while periodically measuring optical density at 600 nm. Exponential growth rates (k = ln2/doubling time) were averaged and charted (±SD).CC BY · PubMed Central
FIG 4 60S ribosome dysfunction alters CDR1 expression and fluconazole susceptibility. (A) Transposon insertion sites and read counts were visualized in a 4 kilobase segment of chromosome A spanning divergently transcribed RPL30 and RPL24A genes for the BG14 and pdr1∆ pools with (red) and without (blue) exposure to fluconazole. Histograms of read coverage were plotted on a log scale. Arrows indicate the 5’ non-coding regions (green) and the 3’ coding regions (yellow) that were enriched after fluconazole exposure in BG14 but not pdr1∆. Exponential growth rates (B), basal CDR1 expression levels (C), and fluconazole resistances (D) of several mutants of the 60S ribosome were quantified in SCD medium at 30°C as described in Materials and Methods.
FIG 4 60S ribosome dysfunction alters CDR1 expression and fluconazole susceptibility. (A) Transposon insertion sites and read counts were visualized in a 4 kilobase segment of chromosome A spanning divergently transcribed RPL30 and RPL24A genes for the BG14 and pdr1∆ pools with (red) and without (blue) exposure to fluconazole. Histograms of read coverage were plotted on a log scale. Arrows indicate the 5’ non-coding regions (green) and the 3’ coding regions (yellow) that were enriched after fluconazole exposure in BG14 but not pdr1∆. Exponential growth rates (B), basal CDR1 expression levels (C), and fluconazole resistances (D) of several mutants of the 60S ribosome were quantified in SCD medium at 30°C as described in Materials and Methods.CC BY · PubMed Central
FIG 5 Translation inhibitors activate Pdr1 and antagonize fluconazole efficacy through engagement of ribosomes. (A) Checkerboard assays of BG14, RPL28-Q38E, and pdr1∆ mutants were determined using varying concentrations of fluconazole plus varying concentrations of cycloheximide (left) or anisomycin (right) as described in Fig. 2. (B) Expression of CDR1 in wild-type (BG14) and RPL28-Q38E mutant strains of C. glabrata was measure by RT-PCR after 1 h exposure to the indicated concentrations of cycloheximide in SCD medium at 30°C. Data points indicate that the average (±SD) of three biological replicates and smooth curves represent best-fit sigmoid equations generated by non-linear regression.
FIG 5 Translation inhibitors activate Pdr1 and antagonize fluconazole efficacy through engagement of ribosomes. (A) Checkerboard assays of BG14, RPL28-Q38E, and pdr1∆ mutants were determined using varying concentrations of fluconazole plus varying concentrations of cycloheximide (left) or anisomycin (right) as described in Fig. 2. (B) Expression of CDR1 in wild-type (BG14) and RPL28-Q38E mutant strains of C. glabrata was measure by RT-PCR after 1 h exposure to the indicated concentrations of cycloheximide in SCD medium at 30°C. Data points indicate that the average (±SD) of three biological replicates and smooth curves represent best-fit sigmoid equations generated by non-linear regression.CC BY · PubMed Central
FIG 6 Fluconazole activates Pdr1 through engagement of Erg11. (A) Western blot analysis of Erg11 and Pdc1 proteins in lysates of BG14 and upc2a∆ cells bearing plasmids pCU-PDC1 (v), pCU-PDC1-ERG11 (ERG11), or pCU-PDC1-ERG11-Y141H,S410F (-DM). (B) The same strains were exposed to varying concentrations of fluconazole for 6 h in SCD medium at 30°C, and then CDR1 expression was quantified using RT-PCR as described in Fig. 3. Data points represent averages of three biological replicates (±SD) and smooth curves represent best-fit sigmoid equations generated by non-linear regression. (C) Fluconazole susceptibility of the same strains was determined as described in Fig. 3.
FIG 6 Fluconazole activates Pdr1 through engagement of Erg11. (A) Western blot analysis of Erg11 and Pdc1 proteins in lysates of BG14 and upc2a∆ cells bearing plasmids pCU-PDC1 (v), pCU-PDC1-ERG11 (ERG11), or pCU-PDC1-ERG11-Y141H,S410F (-DM). (B) The same strains were exposed to varying concentrations of fluconazole for 6 h in SCD medium at 30°C, and then CDR1 expression was quantified using RT-PCR as described in Fig. 3. Data points represent averages of three biological replicates (±SD) and smooth curves represent best-fit sigmoid equations generated by non-linear regression. (C) Fluconazole susceptibility of the same strains was determined as described in Fig. 3.CC BY · PubMed Central
FIG 7 Kinetic analyses of Pdr1 activation and growth inhibition following exposure to cycloheximide and fluconazole. (A) CDR1 expression was monitored by RT-PCR in BG14 cells at different times after exposure to 2 µg/mL cycloheximide, 40 µg/mL oligomycin, 256 µg/mL fluconazole, or 48 µg/mL ketoconazole. Data points represent averages (±SD) of three biological replicates. (B) Growth of BG14 in SCD medium at 30°C was monitored at 600 nm at different times after diluting log-phase cells into fresh medium containing cycloheximide, fluconazole, or ketoconazole at concentrations in A. Data points represent averages (±SD) of three biological replicates, and smooth curves represent best-fit exponential (black, green) or linear (blue, red; t > 90 min) equations using regression.
FIG 7 Kinetic analyses of Pdr1 activation and growth inhibition following exposure to cycloheximide and fluconazole. (A) CDR1 expression was monitored by RT-PCR in BG14 cells at different times after exposure to 2 µg/mL cycloheximide, 40 µg/mL oligomycin, 256 µg/mL fluconazole, or 48 µg/mL ketoconazole. Data points represent averages (±SD) of three biological replicates. (B) Growth of BG14 in SCD medium at 30°C was monitored at 600 nm at different times after diluting log-phase cells into fresh medium containing cycloheximide, fluconazole, or ketoconazole at concentrations in A. Data points represent averages (±SD) of three biological replicates, and smooth curves represent best-fit exponential (black, green) or linear (blue, red; t > 90 min) equations using regression.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 27

Metadata

Authors
Gale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W.
Affiliations
Johns Hopkins University (US)
Corresponding author
Cunningham, Kyle W.
Venue
mSphere
Published
2023-08-24
Volume
8
Issue
4
Pages
e0025423-e0025423
ISSN
2379-5042 (ISSN-L)
OpenAlex
W4382010633
Cited by
27
References
75
Citations by year
2026: 5 · 2025: 9 · 2024: 12 · 2023: 1
FWCI
5.59
Type
journal article
Language
en
Open access
Licence
Locations
  • mSphere (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI153424, R01AI046223)
  • HHS | NIH | National Institute of General Medical Sciences (T32-GM007231)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords
Candida glabrata, pleiotropic drug resistance, fluconazole resistance, antifungal susceptibility, mitochondrial function, oligomycin, cycloheximide, ERG11, sterol biosynthesis, ABC transporters, opportunistic fungal pathogens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrata. https://app.cochat.ai/papers/10.1128/msphere.00254-23
The paper
Gale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W. (2023). Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrata. mSphere. https://doi.org/10.1128/msphere.00254-23

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.